News Daily News FDA: Long-Term Clopidogrel Neither Ups, Nor Cuts Risk of Death in CVD Patients Yael L. Maxwell November 08, 2015
News Daily News No Money, No Drugs: Global Barriers to Secondary CVD Prevention Caitlin E. Cox October 27, 2015
News Industry News Regeneron and Sanofi Announce Approval of Praluent® (alirocumab) for the Treatment of Hypercholesterolemia in the European Union September 28, 2015
News Industry News New Haven Pharmaceuticals Receives FDA Approval for DURLAZA™ (aspirin) Extended Release Capsules for Secondary Prevention of Stroke and Acute Cardiac Events September 08, 2015
News Industry News European Commission Approves Amgen's New Cholesterol-Lowering Medication Repatha™ (evolocumab), The First PCSK9 Inhibitor To Be Approved In The World, For Treatment Of High Cholesterol July 21, 2015
News Daily News Italian Generic Clopidogrel Worse Than Brand Name at Suppressing Platelets Jason Kahn December 13, 2012
News Daily News El Genérico Italiano Clopidogrel es Peor que la Marca Comercial en la Supresión Plaquetaria Jason Kahn December 13, 2012